News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Palantir has transitioned from a speculative story to a high-velocity enterprise AI platform.
  • Commercial AI adoption at Palantir is expanding, driving faster revenue growth.
  • Management is accelerating guidance increases, signaling stronger-than-expected forward momentum.
  • Customer retention and software margins remain high, supporting durable profitability.
  • The company is producing strong free cash flow, strengthening its financial flexibility.
  • Valuation looks rich, but fundamentals and cash generation support a high-conviction long with risk controls.

Latest Articles

Horizon Kinetics Adds to Texas Pacific Land Stake with $408 Purchase

Horizon Kinetics Adds to Texas Pacific Land Stake with $408 Purchase

Horizon Kinetics Asset Management LLC, a significant ten percent shareholder in Texas Pacific Land Corp (TPL), executed a transaction on July 6, 2026, to acquire one share of common stock valued at $408. This acquisition brings the firm's direct holding to 3,263,669 shares, following a previous disclosure of beneficial ownership for over 10 million…

EIA Sees Global Oil Output Back to Pre-War Levels by End of 2026

EIA Sees Global Oil Output Back to Pre-War Levels by End of 2026

The U.S. Energy Information Administration reported that global crude production is projected to return to pre-war volumes by the end of 2026, with most production suspended by the conflict resuming by the first quarter of 2027. The EIA's forecast reflects a faster recovery than earlier expectations and includes revised Brent price estimates for 20…

Amrize Shares Drop After Truist Lowers Rating, Flags Roofing Margin Pressure and Limited Cement Pricing Upside

Amrize Shares Drop After Truist Lowers Rating, Flags Roofing Margin Pressure and Limited Cement Pricing Upside

Amrize shares fell more than 6% on Tuesday after Truist downgraded the building materials firm to Hold from Buy and cut its price target to $48 from $65. The downgrade reflects margin stress in the commercial roofing business and limited near-term upside for cement pricing, while supply shocks to petrochemical inputs and new roofing capacity raise …

UN: World Faces $4 Trillion Annual Shortfall to Meet 2030 Development Goals

UN: World Faces $4 Trillion Annual Shortfall to Meet 2030 Development Goals

A United Nations report warns that a $4 trillion annual financing gap must be closed if the Sustainable Development Goals are to be met by 2030. While the report records notable improvements across some indicators, it highlights deteriorating financing, rising debt, food insecurity and climate pressures that threaten progress.

Vera Therapeutics Receives FDA Accelerated Approval for TRUTAKNA™ for Adult Patients with Primary IgA Nephropathy

Vera Therapeutics Receives FDA Accelerated Approval for TRUTAKNA™ for Adult Patients with Primary IgA Nephropathy

Vera Therapeutics received accelerated FDA approval for TRUTAKNA (atacicept-vymj), the first therapy targeting both BAFF and APRIL to reduce proteinuria in adults with primary IgA nephropathy (IgAN). Clinical trial interim data demonstrated significant proteinuria reduction and an acceptable safety profile, addressing a critical unmet need in kidne…

Why Palantir's AI Moat Is Widening and How to Trade It

Why Palantir's AI Moat Is Widening and How to Trade It

Palantir's enterprise AI platform is moving from bespoke deployments to repeatable product offerings. Strong growth, high margins, improving technicals, and a recent pullback make a disciplined long trade attractive over the next 45 trading days, provided Palantir sustains commercial expansion and earnings power.

Microsoft Shares Tick Up as Company Moves AI Workloads Onto Internal Models

Microsoft Shares Tick Up as Company Moves AI Workloads Onto Internal Models

Microsoft shares rose 1.75% on Tuesday, outpacing a weak Nasdaq after reports that the company has begun replacing third-party AI models with its own MAI technology inside core Office apps. The internal models are reported to be processing tens of thousands of prompts weekly across Excel and Outlook, a shift the company hopes will cut steep AI infr…

Why a Palantir-Nvidia Tie-Up Could Be the Next Big Catalyst for NVDA

Why a Palantir-Nvidia Tie-Up Could Be the Next Big Catalyst for NVDA

Nvidia's leadership in AI compute makes it the natural partner for software platforms like Palantir. If a commercial partnership or strategic deal surfaces, NVDA should see meaningful re-rating. This trade idea lays out a mid-term swing entry at $197.81, a stop at $185.00 and a primary target at $236.54 (52-week high), with clear catalysts and a ri…

London Stocks Close Higher as United Kingdom 100 Rises 0.16%

London Stocks Close Higher as United Kingdom 100 Rises 0.16%

U.K. equity markets ended the session higher, with the Investing.com United Kingdom 100 finishing up 0.16%. Strength in Oil & Gas Producers, Beverage and Food & Drug Retailers underpinned the advance, while individual stocks in pharmaceuticals and advertising posted notable gains. Miners and a telecom operator were among the weakest performers as o…

Madrid Session Ends Lower as IBEX 35 Drops 0.22%

Madrid Session Ends Lower as IBEX 35 Drops 0.22%

Spanish equities finished the day with modest losses as weakness in building and construction, consumer services and financials pulled the IBEX 35 down 0.22%. A handful of large-cap names posted gains, while several renewable and construction-related stocks led declines. Commodities showed divergent direction, with crude rising and gold retreating,…

Portuguese Stocks Finish Higher; PSI Climbs 0.35% on Sector Gains

Portuguese Stocks Finish Higher; PSI Climbs 0.35% on Sector Gains

Portugal's PSI index closed up 0.35% on Tuesday, led by gains in Consumer Services, Basic Materials and Industrials. Jeronimo Martins, Semapa and The Navigator Company were the session's top performers, while EDP Renovaveis, EDP and Banco Comercial Portugues lagged. Commodities were mixed, with Brent and U.S. crude rising and gold retreating; major…

Milan Stocks Slip as Tech, Industrials and Chemicals Lead Declines

Milan Stocks Slip as Tech, Industrials and Chemicals Lead Declines

Italian equities closed lower on Tuesday, with the Investing.com Italy 40 retreating 0.88% in Milan. Losses were concentrated in the Technology, Industrials and Chemicals sectors. While Fincantieri, Davide Campari Milano and Hera finished higher, STMicroelectronics, Prysmian and DiaSorin posted the largest declines. Commodity and FX moves included …

Paris Shares Slip as Tech, Industrial and Financial Stocks Weigh on Market

Paris Shares Slip as Tech, Industrial and Financial Stocks Weigh on Market

French equities ended the session in the red, with the CAC 40 down 0.51% and the broader SBF 120 off 0.57%. Gains in consumer staples and luxury goods stood out, but heavier losses in Technology, Industrials and Financials pulled the market lower. Volume of declining issues surpassed advancing issues by a wide margin, and volatility measures reache…

Helsinki bourse retreats as OMX Helsinki 25 hits three-month low

Helsinki bourse retreats as OMX Helsinki 25 hits three-month low

Finland's main equity gauge fell on Tuesday, with the OMX Helsinki 25 sliding 1.04% to a fresh three-month low. Losses were concentrated in Technology, Telecoms and Industrials even as a handful of heavyweight stocks posted gains. Energy commodities rallied while gold retreated and currency moves were modest.

Drugmakers Intensify Race for Weight-Loss Market as Oral Therapies Rise

Drugmakers Intensify Race for Weight-Loss Market as Oral Therapies Rise

The market for prescription weight-loss therapies has quickly become a focal point for major pharmaceutical companies and smaller biotech firms. With market estimates pointing toward about $100 billion in annual sales within the next decade, developers are pushing a range of agents - from next-generation injectables to novel oral pills - through mi…